| 000 | 01818 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516130036.0 | ||
| 264 | 0 | _c20130924 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1440-1746 | ||
| 024 | 7 |
_a10.1111/jgh.12107 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLo, Gin-Ho | |
| 245 | 0 | 0 |
_aControlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cApr 2013 |
||
| 300 |
_a684-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aEsophageal and Gastric Varices _xmortality |
| 650 | 0 | 4 | _aEsophagoscopy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xmortality |
| 650 | 0 | 4 | _aHemostasis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigation |
| 650 | 0 | 4 |
_aLypressin _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmeprazole _xadverse effects |
| 650 | 0 | 4 | _aPantoprazole |
| 650 | 0 | 4 |
_aProton Pump Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSomatostatin _xadverse effects |
| 650 | 0 | 4 | _aTerlipressin |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xadverse effects |
| 700 | 1 | _aPerng, Daw-Shyong | |
| 700 | 1 | _aChang, Chi-Yang | |
| 700 | 1 | _aTai, Chi-Ming | |
| 700 | 1 | _aWang, Huay-Min | |
| 700 | 1 | _aLin, Hui-Chen | |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 28 _gno. 4 _gp. 684-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jgh.12107 _zAvailable from publisher's website |
| 999 |
_c22382803 _d22382803 |
||